Propecia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
Conditions: Adenocarcinoma of the Prostate; Stage II Prostate CancerInterventions: Drug: finasteride; Other: placebo; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2007 Category: Research Source Type: clinical trials

A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)
Condition: Benign Prostatic HyperplasiaInterventions: Drug: MK0906, finasteride / Duration of Treatment: 48 weeks; Drug: Comparator: placebo / Duration of Treatment: 48 weeksSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2005 Category: Research Source Type: clinical trials

A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)
Condition: Benign Prostatic HyperplasiaInterventions: Drug: MK0906, finasteride / Duration of Treatment: 48 weeks; Drug: Comparator: placebo / Duration of Treatment: 48 weeksSponsor: Merck Sharp & Dohme Corp.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2005 Category: Research Source Type: clinical trials